Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
3.13B
Enterprise Value
3.82B
Income
154.71M
Sales
1.79B
Book/sh
52.33
Cash/sh
22.57
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
0.00%
Employees
7806
IPO
Oct 02, 1997
P/E
21.88
Forward P/E
15.34
PEG
1.25
P/S
1.75
P/B
3.76
P/C
8.71
P/FCF
12.78
EV/EBITDA
13.98
EV/Sales
2.14
Quick Ratio
2.34
Current Ratio
3.15
Debt/Eq
1.26
LT Debt/Eq
1.24
Option/Short
Yes / Yes
EPS (ttm)
8.98
EPS next Y
12.82
EPS next Q
1.65
EPS this Y
9.86%
EPS next Y
12.73%
EPS next 5Y
12.28%
EPS past 3/5Y
18.81% 17.33%
Sales past 3/5Y
11.79% 9.26%
EPS Y/Y TTM
4.70%
Sales Y/Y TTM
4.25%
EPS Q/Q
7.83%
Sales Q/Q
-4.14%
Insider Own
5.64%
Insider Trans
-2.18%
Inst Own
121.50%
Inst Trans
-0.97%
ROA
6.52%
ROE
17.34%
ROIC
8.29%
Gross Margin
30.82%
Oper. Margin
12.93%
Profit Margin
8.66%
SMA20
0.57%
SMA50
-3.41%
SMA200
-18.24%
Trades
Shs Outstand
15.92M
Shs Float
15.04M
52W High
311.72 -36.93%
52W Low
186.50 5.42%
Volatility
2.28% 2.52%
ATR (14)
5.16
RSI (14)
47.38
Beta
1.27
Rel Volume
0.62
Avg Volume
228.08K
Volume
139,720
Perf Week
2.04%
Perf Month
-2.11%
Perf Quarter
-8.29%
Perf Half Y
-32.79%
Perf YTD
-22.92%
Perf Year
-21.94%
Perf 3Y
71.08%
Perf 5Y
105.70%
Perf 10Y
196.76%
Prev Close
194.86
Price
196.61
Change %
0.90%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CHOPRA DEEPAKDirectorMay 04 '26Sale281.8420,0005,636,800253,044May 05 04:00 PM
CHOPRA FAMILY TRUST U/A DTD12/DirectorMay 04 '26Proposed Sale282.5020,0005,650,000May 04 04:28 PM
CHOPRA DEEPAKDirectorFeb 02 '26Sale250.9120,0005,018,200273,044Feb 04 04:00 PM
CHOPRA FAMILY TRUST U/A DTD12/DirectorFeb 02 '26Proposed Sale250.1420,0005,002,800Feb 02 04:29 PM
CHOPRA DEEPAKEXECUTIVE CHAIRMANNov 10 '25Sale285.7420,0005,714,800292,969Nov 12 02:43 PM
CHOPRA FAMILY TRUST U/A DTD12/DirectorNov 10 '25Proposed Sale284.8620,0005,697,200Nov 10 04:35 PM
Morben Paul KeithPRES., OPTOELECTRONICS DIVNov 07 '25Sale279.10416116,1068,540Nov 07 09:50 PM
HAWKINS JAMES BDirectorNov 07 '25Sale283.151,500424,7255,036Nov 07 09:50 PM
PAUL MORBENOfficerNov 07 '25Proposed Sale279.10416116,106Nov 07 04:28 PM
JAMES HAWKINSDirectorNov 07 '25Proposed Sale283.151,500424,719Nov 07 04:26 PM
OSI Systems, Inc. engages in the design and manufacture of specialized electronic systems and components for critical applications. It operates through the following segments: Security, Optoelectronics and Manufacturing, Healthcare, and Corporate and Eliminations. The Security segment includes security and inspection systems, and turnkey security screening solutions. The Optoelectronics and Manufacturing segment refers to electronic components and electronic manufacturing services. The Healthcare segment focuses on the provision of patient monitoring, cardiology and remote monitoring, connected care systems, and associated accessories. The Corporate and Eliminations segment represents the executive compensation and certain other general and administrative expenses. The company was founded by Deepak Chopra in 1987 and is headquartered in Hawthorne, CA.
PresidentMr. Ajay Mehra
Executive VP & CFOMr. Alan I. Edrick
Executive VPMr. Victor S. Sze
CTO of Optoelectronics & Manufacturing DivisionMr. Aliabadi Manoocher Mansouri
President of Optoelectronics & Manufacturing DivisionMr. Paul Keith Morben
HBIO Harvard Bioscience Inc daily Stock Chart
Index
-
Market Cap
38.56M
Enterprise Value
76.27M
Income
-10.41M
Sales
87.81M
Book/sh
1.63
Cash/sh
1.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
339
IPO
Dec 07, 2000
P/E
-
Forward P/E
13.13
PEG
-
P/S
0.44
P/B
5.20
P/C
5.93
P/FCF
-
EV/EBITDA
12.78
EV/Sales
0.87
Quick Ratio
0.98
Current Ratio
1.87
Debt/Eq
5.96
LT Debt/Eq
5.74
Option/Short
No / Yes
EPS (ttm)
-2.32
EPS next Y
0.65
EPS next Q
-0.17
EPS this Y
-90.00%
EPS next Y
269.74%
EPS next 5Y
-
EPS past 3/5Y
-77.14% -44.59%
Sales past 3/5Y
-8.60% -3.25%
EPS Y/Y TTM
82.17%
Sales Y/Y TTM
-1.06%
EPS Q/Q
-24.83%
Sales Q/Q
11.13%
Insider Own
7.15%
Insider Trans
0.00%
Inst Own
41.71%
Inst Trans
3.20%
ROA
-13.32%
ROE
-89.95%
ROIC
-20.81%
Gross Margin
54.35%
Oper. Margin
0.65%
Profit Margin
-11.86%
SMA20
3.17%
SMA50
7.39%
SMA200
33.15%
Trades
Shs Outstand
4.55M
Shs Float
4.23M
52W High
9.40 -9.89%
52W Low
3.95 114.43%
Volatility
5.09% 3.74%
ATR (14)
0.32
RSI (14)
61.35
Beta
1.50
Rel Volume
0.58
Avg Volume
17.92K
Volume
10,318
Perf Week
3.93%
Perf Month
6.94%
Perf Quarter
36.83%
Perf Half Y
26.61%
Perf YTD
26.64%
Perf Year
106.59%
Perf 3Y
-80.21%
Perf 5Y
-88.02%
Perf 10Y
-68.04%
Prev Close
8.34
Price
8.47
Change %
1.56%
Date Action Analyst Rating Change Price Target Change
Apr-09-25Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-10-23Upgrade The Benchmark Company Speculative Buy → Buy $3 → $4
Jan-07-21Upgrade The Benchmark Company Speculative Buy → Buy
Dec-09-20Initiated Northland Capital Outperform $6
Nov-10-20Initiated KeyBanc Capital Markets Overweight $6
Jul-08-19Downgrade Janney Buy → Neutral $2
Jan-24-18Reiterated Janney Buy $5 → $8
Jan-23-18Reiterated The Benchmark Company Buy $6 → $10
Nov-17-16Initiated Singular Research Buy $5.50
Jul-28-15Initiated The Benchmark Company Buy $8
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Frost Mark TChief Financial OfficerMar 16 '26Buy5.005,00025,00017,500Apr 01 09:44 AM
DENELSKY STEPHEN JDirectorMar 17 '26Buy4.8710,00048,70021,000Mar 18 02:13 PM
Snider WilliamDirectorMar 16 '26Buy4.9912,52562,50023,525Mar 18 07:31 AM
Snider WilliamDirectorMar 17 '26Buy4.858,47541,10432,000Mar 18 07:31 AM
Duke John DChief Executive OfficerMar 16 '26Buy5.015,00025,050105,000Mar 17 05:56 PM
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, China, United Kingdom, and Rest of the World. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA.
PresidentMr. John Duke
CFOMr. Mark T. Frost
Vice President of Global People OperationsMs. Lori Packer
Senior Vice President of CommercialMr. David Panzarella
Corporate ControllerKathryn Flynn